Clinical Trial: Clinical Lid Eradication of Antifungal-Responsive FUNGUS Study

U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07856680) titled 'Clinical Lid Eradication of Antifungal-Responsive FUNGUS Study' on Sept. 28.

Brief Summary: The goal of this clinical trial is to learn if Natacyn works to reduce or eliminate laboratory-confirmed fungal organisms in subjects with fungal-positive blepharitis identified in a previous study. asthma in adults. It will also learn more about the safety of Natacyn. The main questions it aims to answer are:

Does Natacyn reduce or eliminate fungal presence? Does Natacyn cause a reduction in eye irritation and itchiness? What medical problems do participants have when using Natacyn?

Participants will:

Apply Natacyn 4 times a day for 21 day...